Paller, Amy S. http://orcid.org/0000-0001-6187-6549
Flohr, Carsten
Eichenfield, Lawrence F.
Irvine, Alan D.
Weisman, Jamie
Soung, Jennifer
Pinto Correia, Ana
Natalie, Chitra R.
Rodriguez Capriles, Claudia
Pierce, Evangeline
Reifeis, Sarah
Gontijo Lima, Renata
Armengol Tubau, Clara
Laquer, Vivian
Weidinger, Stephan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
https://doi.org/10.1007/s13555-023-00942-y
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 15 March 2023
Accepted: 17 May 2023
First Online: 15 June 2023